Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-02-23 @ 5:35 PM
Study NCT ID:
NCT02077959
Status:
TERMINATED
Last Update Posted:
2023-01-27
First Post:
2014-02-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Ohio State University Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-03
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-28
First Submit QC Date:
None
Study First Post Date:
2014-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-14
Last Update Post Date:
2023-01-27
Last Update Post Date Type:
ACTUAL